Loading...
•
Apr 03, 2021
Perrigo Q1 2021 Earnings Report
Perrigo's transformation into a consumer self-care company neared completion, with Q1 results reflecting pandemic-related distortions but remaining in line with expectations.
Key Takeaways
Perrigo reported a decrease in net sales and adjusted EPS for Q1 2021, primarily due to pantry loading in the prior year and a weak cough/cold season. However, the company reaffirmed its full-year guidance, citing strong business fundamentals and anticipated improvements in retail traffic and cough/cold incidence.
Net sales decreased by 6.8% to $1.01 billion, impacted by pantry loading and weak cough/cold season.
Adjusted diluted EPS decreased by 25.4% to $0.50, also affected by pandemic-related factors.
CSCA net sales decreased by 8.6% to $641 million, while CSCI net sales decreased by 3.4% to $370 million.
Fiscal year 2021 outlook reaffirmed, with expectations of 3% organic net sales growth, 5% adjusted operating income growth, and 7% adjusted diluted EPS growth.
Revenue by Segment
Forward Guidance
The Company reaffirmed its fiscal 2021 outlook and expects to deliver 3% organic net sales growth, 5% adjusted operating income growth and 7% adjusted diluted EPS growth, translating into an adjusted diluted EPS range of $2.50 to $2.70.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...